Genpact Signs Five-Year Contract Extension with Major Pharmaceutical Company for Finance and Accounting Business Process

 Genpact Signs Five-Year Contract Extension with Major Pharmaceutical Company
       for Finance and Accounting Business Process Management Services

PR Newswire

NEW YORK, Jan. 15, 2013

NEW YORK, Jan. 15, 2013 /PRNewswire/ --Genpact Limited (NYSE: G), a global
leader in business process management and technology services, today announced
it has been awarded a five-year contract extension by global pharmaceutical
leader GlaxoSmithKline (GSK) for finance and accounting (F&A) services. Under
this agreement, Genpact will continue to deliver global services such as
accounts payable, record-to-report, and order-to-cash across several global
regions, supporting GSK's drive to standardize core business processes and
services.

(Logo: http://photos.prnewswire.com/prnh/20120501/NY98560LOGO )

Paul Fry, senior vice president for Finance Services in GSK's Core Business
Services said, "Our continued partnership with Genpact is a key element in our
drive to deliver simpler, more efficient and standardized business processes
for GSK."

"Over the last six years, the partnership between Genpact and GSK has been
able to address GSK's growing global business and the unique challenges within
the pharmaceutical market while improving the outcomes of these end-to-end
processes, especially through our Lean and Six Sigma framework," said BK
Kalra, senior vice president and business leader, Life Sciences, Genpact.
"We are thrilled to expand our valued relationship with GSK and ensure
continuous process effectiveness so that their path to future growth is
smooth."

Genpact provides business process management and technology services to 8 of
the top ten global pharmaceutical companies. Genpact helps them to make their
end-to-end F&A processes more effective, address regulatory changes, make use
of customer and market data through its analytics services, and improve pharma
companies' customer service operations through intelligent technology
solutions. More information can be accessed at
http://www.genpact.com/home/industries/life-sciences.

About GSK
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and
healthcare companies – is committed to improving the quality of human life by
enabling people to do more, feel better and live longer. For further
information please visit www.gsk.com.

About Genpact
Genpact Limited (NYSE: G), a global leader in business process management and
technology services, leverages the power of smarter processes, smarter
analytics and smarter technology to help its clients drive intelligence across
their enterprise. Genpact's Smart Enterprise Processes (SEP^SM) framework,
its unique science of process combined with deep domain expertise in multiple
industry verticals, leads to superior business outcomes. Genpact's Smart
Decision Services deliver valuable business insights to its clients through
targeted analytics, reengineering expertise, and advanced risk management.
Making technology more intelligent by embedding it with process and data
insights, Genpact also offers a wide range of technology services. Driven by
a passion for process innovation and operational excellence built on its Lean
and Six Sigma DNA and the legacy of serving GE for more than 15 years, the
company's 60,500+ professionals around the globe deliver services to its more
than 600 clients from a network of 74 delivery centers across 20 countries
supporting more than 30 languages. For more information, visit
www.genpact.com. Follow Genpact on Twitter, Facebook and LinkedIn.

For more information:
Gail Marold (Genpact Media   Barbara Tate (For Genpact Rupali Kathuria (For
Relations)                   U.S.)                     Genpact India)

gail.marold@genpact.com      barbara.tate@ogilvy.com   rupali.kathuria@bm.com
                                                       +91 124 441 75
+1 919-345-3899              +1 212-880-5338



SOURCE Genpact Limited

Website: http://www.genpact.com
 
Press spacebar to pause and continue. Press esc to stop.